IJJ Corp (IJJP)

[rayinbrooklyn65]

IJJP: Ray's Thoughts for His Post Today: 03/26/2015

IJJP has traded fractionally lower (- 0.0001) in today's mid-day trading session on relatively healthy volume (43.7 million shares). The steep drop in the accumulation has leveled off after Monday's huge sell-off as investors are re-entering the market purchasing shares in the upper 0.001s to recapture shares they believe to be (and in actuality are) deeply discounted.

Fundamental Factors:

The company has demonstrated performance not just in words, but more importantly in the actions it has taken and accomplished within the past several months to bring value to shareholders through successful completion of the following:

1. The company is currently working on multiple deals to further develop, expand, and fortify its footprint in the what is certain to be the most lucrative spectrum of the medical marijuana industry: the cultivation of marijuana for distribution to the medical industry.
2. By concentrating on the "supply side" of the business through the company's development of agricultural partnerships with entities who already have the land readily available and the knowledgeable labor to cultivate marijuana, IJJP management is demonstrating the wisdom and foresight to focus on the less-regulated and less-complicated supply sector of the business as opposed to dealing with the myriad of federal, state, and local regulations stacked upon one another that are often confusing and often contradictory that the retail point of sale sector will have to contend with. Appropriate parallel industries which appropriately illustrate this point are the liquor ad tobacco industries.
3. IJJP has entered into strategic partnerships with American Seed & Oil to build the treatment facility and cultivate cannabis.
4. IJJP has forged a key alliance with Agra Medical Global Holdings Inc. (AMGH) to cultivate cannabis on land in collaboration with Native Americans.
5. IJJP has closed agreements with World of Marijuana Productions Ltd. and with Michigan Plant Technologies LLC that will provide IJJP with residual annual income of $2.1 million.
6. IJJP management has exercised fiscal prudence and shown consideration for the value of shareholders' investment by addressing administrative matters within their own corporate house by recently completing the following measures:
-- a. The reduction in common stock by 500 million shares.
-- b. Hiring an independent third party firm to conduct an audit of the short sale activity dating back to August 2009 for the purpose of uncovering abusive and illegal "naked" short selling activity which has artificially diluted the price of the stock thus eroding the value shareholders' investments.
7. IJJP management has demonstrated excellent transparency by consistently communicating with the investment community through the issuance of press releases updating shareholders of recent corporate activity. Within the month of March alone, IJJP has published seven press releases corroborating its various activities within the industry to solidify partnerships that will grow their business, generate revenue, and lead to greater corporate accountability.
8. The current social, legislative, and medical climate has swung in favor of sanctioning the use of marijuana for medical treatment of glaucoma, to alleviate chronic pain caused by such ailments as cancer and debilitating arthritis, and ease stress resulting from such psychological disorders as acute anxiety and post traumatic stress. Currently the use of medical marijuana is legal in 23 states and in the District of Columbia; further, referendums for legalization of medical marijuana are protected to be on the ballots of an additional ten states ready for a vote in this November's election cycle. Even moderate Republican presidential candidates are uniting with Democrats to author federal legislation to sanction the use of medical marijuana.

Technical Analysis:

1. We have formed a solid base in the 0.0015 to 0.0018 with nearly 100 million shares trading here over the past several trading sessions.
2. The chart has re-set itself with highly watched technical guidepost such as the RSI at 34.57 showing the stock to be OVERSOLD at these price levels.
3. The price has remained continuously above the 200-Day Moving Average, which is and essential level of support to keep the chart intact.

Chart:


Investor Takeaways:

1. Those remaining invested in IJJP should feel confident the stock has reached a nadir at the 0.0015 price level, will remain above the 200-Day Moving Average, and will begin its ascent up the chart through consistently increasing share prices.
2. IJJP management continues to get its financial house in order finalizing measures that will enable it to become even more transparent with the investment community.
3. IJJP is continuing to build upon the key alliances it has already established to further broaden its presence in the nascent marijuana cultivation industry. These liaisons will enable IJJP to yield substantial profits cultivating this increasingly sought-after and most profitable commodity.
4. The cultural, legal, and medical tide has significantly swung in favor of legitimizing the use of medical marijuana.

These are my thoughts for today. I look forward to a significant resurgence in the price of IJJP's stock price predicated on the aforementioned points highlighted in this posting. Patience and persistence is what is needed for this to fully succeed.


Regards,

Ray